Harmreduction.eu

EUDA has launched the Civil Society Platform on Drugs, a new online space designed for consultation, knowledge sharing and meaningful dialogue.

EUDA invites NGOs, voluntary and community organisations, individuals with lived experience, and representatives of affected communities.

🔗 Learn more:

EUDA engagement with civil society | The European Union Drugs Agency (EUDA) Civil society plays a key role in shaping policy, providing social and community services, highlighting important issues, and giving a voice to diverse groups, including people in vulnerable situations.

Latest UK HIV statistics are out.

The UK Health Security Agency’s 2024 report shows progress, but also persistent challenges:
⚠️ 42% of new HIV diagnoses were late diagnoses. This is linked to a 10-fold higher risk of death in the first year after diagnosis.

✅ On the positive side, opt-out HIV testing in emergency departments is working, PrEP uptake is rising, and overall new HIV diagnoses are decreasing.

❗However, serious disparities remain: among people at high risk, Black and ethnically minoritised groups are accessing PrEP at much lower rates than white people.

📖 Read full summary and expert commentary

HIV i-Base Easy to read HIV treatment guides based on the latest guidelines, HIV treatment Q and A service, reports on the latest HIV research.

What are the main drug-related threats today? Which substances are causing the most concern? How are countries responding to Europe’s evolving drug issues? Find out more in the European Drug Report 2025: Trends and Developments.
As the drug landscape continues to evolve, this new report provides valuable insights into current challenges and future risks. Drawing on data from 29 countries (the EU's 27 member states, Turkey and Norway), the report examines long-term trends and emerging threats. Its comprehensive analysis covers drug use and supply, as well as drug-related harms and how they are addressed.

📖 Explore the full report: euda.europa.eu/publications/european-drug-report/2025_en